Corvus Pharmaceuticals (CRVS) Net Shares Issued and Repurchased (2016 - 2026)
Corvus Pharmaceuticals (CRVS) posted quarterly Net Shares Issued and Repurchased of -$1000.0 for Q4 2016, down 100.01% quarter-over-quarter from $7.0 million in Q2 2016.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Net Shares Issued and Repurchased (2016 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Net Shares Issued and Repurchased history runs 1 years deep, the most recent figure standing at -$1000.0 for Q4 2016.
- In Q4 2016, Net Shares Issued and Repurchased changed N/A year-over-year to -$1000.0; the TTM figure through Dec 2016 stood at $71.4 million (changed N/A YoY), while the FY2016 annual figure was $71.4 million, changed N/A from the prior year.
- Net Shares Issued and Repurchased for Q4 2016 stood at -$1000.0, down from $7.0 million in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $64.3 million in Q1 2016, with the low at -$1000.0 in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Corvus Pharmaceuticals | 1.33 Bn | 1.12 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 661,334.00 |
| Dec 31, 2025 | 2.93 Mn |
| Mar 31, 2025 | 269,735.00 |
| Dec 31, 2024 | 2.81 Mn |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 2.54 Mn |
| Mar 31, 2023 | 860,000.00 |
| Dec 31, 2022 | 1.71 Mn |
| Mar 31, 2022 | 652,720.00 |
| Dec 31, 2021 | 1.65 Mn |
| Mar 31, 2021 | 455,788.00 |
| Dec 31, 2020 | 1.62 Mn |
| Mar 31, 2020 | 100,000.00 |
| Dec 31, 2019 | 2.03 Mn |
| Mar 31, 2019 | 277,000.00 |
| Dec 31, 2018 | 1.45 Mn |
| Mar 31, 2018 | 189,000.00 |
| Dec 31, 2017 | 969,500.00 |
| Mar 31, 2017 | 58,000.00 |
| Dec 31, 2016 | -1,000.00 |